Core Insights - UnitedHealth Group stock has declined by 7% over the past month due to rising medical costs in Medicare Advantage plans, regulatory scrutiny, and margin pressures in the Optum division [2] - The stock has decreased by 46.5% over the last year, underperforming compared to competitors CVS and CNC, and currently has a PE ratio of 16.9 [4] Financial Performance - UnitedHealth maintains the highest operating margin among its peers at 6.1% [3] - The company reported a revenue growth of 10.5% over the past 12 months, which is robust but still trails behind competitors CNC and MOH [3] Market Position - The recent 8.7% decline in stock price highlights the importance of comparing UnitedHealth's performance with its peers to assess whether it is genuinely underperforming [6] - The Trefis High Quality Portfolio has consistently outperformed its benchmark, indicating that a diversified investment strategy may offer better risk-adjusted returns compared to investing in individual stocks like UnitedHealth [5][7]

Core Insights - The article discusses the importance of the price-to-book (P/B) ratio as a tool for value investing, highlighting its utility in identifying undervalued stocks with strong growth potential [1][2]. Group 1: Understanding P/B Ratio - The P/B ratio is calculated by dividing the current stock price by the book value per share, indicating how much investors pay for each dollar of book value [2][6]. - A P/B ratio of less than one suggests that a stock is undervalued, while a ratio greater than one indicates overvaluation [6][7]. - The P/B ratio is particularly relevant for industries with tangible assets, such as finance and manufacturing, but may be misleading for companies with high R&D expenses or significant debt [9][10]. Group 2: Screening Criteria for Value Stocks - Stocks with a P/B ratio lower than the industry median are considered attractive, as they have room for price appreciation [12]. - Additional screening parameters include a lower price-to-sales (P/S) ratio than the industry median, a price-to-earnings (P/E) ratio below the industry average, and a PEG ratio of less than one, indicating undervaluation relative to growth prospects [13][14][15]. - Stocks must also have a minimum trading price of $5 and a substantial average trading volume to ensure liquidity [14][15]. Group 3: Selected Low P/B Stocks - StoneCo (STNE) offers financial technology solutions and has a projected 3-5 year EPS growth rate of 30.3%, with a Zacks Rank of 1 and a Value Score of B [16]. - PagSeguro Digital (PAGS) provides digital payment solutions and has a projected EPS growth rate of 14.2%, also holding a Zacks Rank of 1 and a Value Score of B [17]. - KT Corporation (KT) is a telecommunications provider with a projected EPS growth rate of 51.7% and a Zacks Rank of 2 with a Value Score of A [19]. - Arrow Electronics (ARW) is a major distributor of electronic components, with a projected EPS growth rate of 20.7% and a Zacks Rank of 2 with a Value Score of A [19]. - CVS Health has a projected EPS growth rate of 14.3% and holds a Zacks Rank of 2 with a Value Score of A [20].

Core Insights - The article discusses the importance of the price-to-book (P/B) ratio in value investing, highlighting its utility in identifying undervalued stocks with strong growth potential [1][2]. Group 1: Understanding P/B Ratio - The P/B ratio is calculated by dividing the current stock price by the book value per share, indicating how much investors pay for each dollar of book value [2][6]. - A P/B ratio of less than one suggests that a stock is undervalued, while a ratio greater than one indicates it may be overvalued [6][7]. - The P/B ratio is particularly relevant for industries with tangible assets, such as finance and manufacturing, but may be misleading for companies with high R&D expenses or negative earnings [9][10]. Group 2: Investment Opportunities - Five stocks identified as having low P/B ratios include StoneCo (STNE), CVS Health (CVS), KT Corporation (KT), KB Financial Group (KB), and USANA Health Sciences (USNA) [11][16]. - These stocks have Zacks Rank 1 or 2 and Value Scores of A or B, with projected EPS growth rates ranging from 11.9% to 49.9%, indicating strong potential [11][17][19][20][21]. Group 3: Screening Parameters - Screening parameters for identifying attractive stocks include P/B ratio less than the industry median, P/S ratio less than the industry median, and P/E ratio less than the industry median [12][13]. - A PEG ratio of less than 1 indicates undervaluation relative to future growth prospects, while a minimum stock price of $5 and an average trading volume of at least 100,000 are also considered [14][15].

Core Insights - The article discusses the importance of various valuation metrics, particularly focusing on the price-to-book (P/B) ratio as a tool for identifying undervalued stocks with high growth potential [1][5][9]. Valuation Metrics - The price-to-earnings (P/E) ratio is often the first metric considered, but it becomes negative for loss-making companies, making the price-to-sales (P/S) ratio a more relevant indicator in such cases [1]. - The P/B ratio is calculated by dividing the current stock price by the book value per share, helping investors understand how much they pay for each dollar of book value [2][5]. - A P/B ratio of less than one indicates that a stock is trading below its book value, suggesting it may be undervalued and a good buy [5][6]. Book Value - Book value represents the total value left for shareholders if a company were to liquidate its assets after settling all liabilities [3][4]. - It is calculated by subtracting total liabilities from total assets, and in some cases, intangible assets should also be deducted [4]. Stock Examples - StoneCo (STNE), CVS Health (CVS), KT Corporation (KT), KB Financial Group (KB), and USANA Health Sciences (USNA) are highlighted as stocks with low P/B ratios and strong growth potential [9][15][16][18][19]. - STNE has a projected 3-5 year EPS growth rate of 25.3% and a Zacks Rank of 1, while CVS has a projected EPS growth rate of 11.4% and a Zacks Rank of 2 [15][16]. Screening Parameters - Stocks are screened based on several parameters, including P/B, P/S, P/E ratios, PEG ratio, trading price, average volume, Zacks Rank, and Value Score [11][12][13][14]. - A PEG ratio of less than 1 indicates that a stock is undervalued relative to its growth prospects [13]. Limitations of P/B Ratio - The P/B ratio is most useful for companies in finance, investments, and manufacturing with tangible assets, but may be misleading for firms with high R&D expenditures or significant debt [8].

Group 1 - Zacks Premium offers various tools to help investors become more confident and informed, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] - The Zacks Style Scores are complementary indicators that rate stocks based on value, growth, and momentum, helping investors identify stocks with the best chances of outperforming the market in the short term [3][4] Group 2 - The Value Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, and Price/Sales, appealing to value investors [4] - The Growth Score emphasizes a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow to find stocks with sustainable growth [5] - The Momentum Score identifies trends in stock prices and earnings outlooks, assisting momentum traders in timing their investments based on recent price changes [6] Group 3 - The VGM Score combines the Value, Growth, and Momentum Scores, providing a comprehensive rating that helps investors find stocks with attractive value, strong growth potential, and positive momentum [7] - The Zacks Rank, a proprietary stock-rating model, uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8][9] Group 4 - CVS Health Corporation is highlighted as a stock to watch, currently rated 2 (Buy) on the Zacks Rank with a VGM Score of A, indicating strong potential [12] - CVS has a Value Style Score of A, supported by a forward P/E ratio of 10.89, making it attractive to value investors [13] - Recent upward revisions in earnings estimates by 12 analysts and an increase in the Zacks Consensus Estimate to $6.11 per share further enhance CVS's investment appeal, alongside an average earnings surprise of 18.1% [13]

Core Insights - The Zacks Premium service provides tools for investors to enhance their stock market engagement and confidence, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1] Zacks Style Scores - Zacks Style Scores are indicators designed to help investors select stocks with the highest potential to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] Value Score - The Value Style Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow to find attractive investment opportunities [3] Growth Score - The Growth Style Score evaluates a company's future growth potential by analyzing projected and historical earnings, sales, and cash flow, targeting stocks with sustainable growth [4] Momentum Score - The Momentum Style Score identifies optimal entry points for stocks based on price trends and earnings estimate changes, emphasizing the importance of following market trends [5] VGM Score - The VGM Score combines Value, Growth, and Momentum scores, providing a comprehensive assessment of stocks to identify those with the best overall potential [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [7][8] Stock Selection Strategy - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B to maximize potential success, while stocks with lower ranks should also have strong Style Scores to mitigate risks [9][10] Company Spotlight: CVS Health - CVS Health Corporation, a pharmacy innovation company, is currently rated 3 (Hold) with a VGM Score of B, indicating a stable position in the market [11] - CVS has a Value Style Score of A, supported by a forward P/E ratio of 11.79, making it attractive for value investors [12] - Recent upward revisions in earnings estimates for fiscal 2025 have increased the Zacks Consensus Estimate by $0.04 to $5.89 per share, with an average earnings surprise of 18.1%, positioning CVS as a noteworthy investment option [12]